Sarah Cannon will present its latest cancer research insights through more than 100 abstracts and presentations at the ASCO® Annual Meeting focused on “Caring for Every Patient, Learning from Every Patient.” Our experts will participate in a number of presentations and educational sessions focused on immunotherapies, including cellular therapy, and targeted investigational agents that are transforming the delivery of cancer care for patients. Come see us at booth #2062.View Press Release
Learn about the history of Sarah Cannon, our scope and scale and how we are advancing therapies for patients across the U.S. and UK.
Get to know the physicians and administrative leadership who are advancing science and transforming cancer care.
Sarah Cannon offers a helpline, askSARAH, so that people with cancer questions can talk to a specially-trained nurse to receive trusted information.
About Sarah Cannon
Sarah Cannon Research Institute is the research arm of HCA Healthcare’s Cancer Institute, Sarah Cannon. Focused on advancing therapies for patients, it is one of the world’s leading clinical research organizations conducting community-based clinical trials throughout the United States and United Kingdom. A leader in drug development, Sarah Cannon has led more than 370 first-in-man clinical trials since its inception in 1993, and has been a clinical trial leader in the majority of approved cancer therapies over the last 10 years.
Sarah Cannon physicians and leadership are available for interview at the 2019 ASCO® Annual Meeting. Please contact the below regarding media opportunities.